These data suggest that small variations in DNA methylation correlate with relevant changes in expression of APBA2 and APBA3. In summary our results indicate an increase in DNA methylation in samples of BPD patients compared to controls at several gene specific CpG sites and this may lead to a decreased expression of the respective genes. This evidence concerns the gene APBA2 and Borderline personality disorder.